title: Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
authors.affiliation: Department of Cardiology, Cardiovascular Institute, Hospital Clínic de Barcelona, Barcelona, Spain.
authors.forename: Elena
authors.initials: E
authors.lastname: Arbelo
authors.affiliation: Department of Pediatric Cardiology, Hospital San Joan de Deu, Barcelona, Spain.
authors.forename: Georgia
authors.initials: G
authors.lastname: Sarquella-Brugada
authors.affiliation: Department of Cardiology, Cardiovascular Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Department of Pediatric Cardiology, Hospital San Joan de Deu, Barcelona, Spain. Electronic address: jbrugada@clinic.ub.es.
authors.forename: Josep
authors.initials: J
authors.lastname: Brugada
mesh_terms: D004562:Electrocardiography; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000628:therapy*; D008297:Male; D008801:Mexiletine / Q000008:administration & dosage*
chemical_list: D008801:Mexiletine
keywords: arrhythmia; mutation; sodium-channel blocker; sudden cardiac death